← All stocks

Lexaria Bioscience Corp.

LEXX Net buying

CIK 0001348362 #5058 in the set updated 21 Sep 2026

Bought (120 mo)

$219.40K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$105.27K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$105.27K

4 of 4 sales

Net

+$114.13K

+$114.13K against sales at will

By person

10 insiders · 34 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

CHRISTOPHER RICHARD

Chief Executive Officer

$132.03K (3)

—

+$132.03K

65,000

$59.35K

—

McKechnie William Edward

Director

$4.53K (1)

$95.00K (3)

−$90.47K

18,191

$16.61K

—

BUNKA CHRISTOPHER

Director

$67.89K (16)

—

+$67.89K

7,226,754

$6.60M

+16.7%

Carle Vanessa

Secretary

$682.50 (1)

$10.27K (1)

−$9.59K

750

$684.83

+1,019%

TURKEL CATHERINE C.

Director

$9.27K (2)

—

+$9.27K

3,100

$2.83K

—

DOCHERTY JOHN MARTIN

President & CSO

$4.99K (1)

—

+$4.99K

59,451

$54.28K

—

Spissinger Allan Horst

Chief Financial Officer

—

119,116

$108.76K

+333.9%

Baxter Nicholas W

Director

—

11,000

$10.04K

—

REESE ALBERT L JR

Director

—

10,917

$9.97K

+1,091%

Downey Gregory

Chief Financial Officer

—

1,954

$1.78K

+6.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 133

Amendments (4/A) skipped 3

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 3,346,455

Sales filed before the plan box existed 3

History held since 6 Oct 2016